» Articles » PMID: 12111870

Isotype Class Switching and the Pathogenesis of Multiple Myeloma

Overview
Journal Hematol Oncol
Specialties Hematology
Oncology
Date 2002 Jul 12
PMID 12111870
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Translocations at the immunoglobulin heavy chain locus (14q32) are now considered the commonest karyotypic change in multiple myeloma. These translocations are thought to be intimately involved in the pathogenesis of this disease. The heavy chain locus is strongly transcriptionally active in B and plasma cells and transfer of a potential oncogene to 14q32 would result in its dysregulation. Molecular characterization suggests that the majority of these breakpoints cluster in switch regions within the heavy chain locus. Switch regions are normally involved in the regulated process of isotype switching so that in myeloma the rearrangements are believed to be a result of so-called illegitimate (aberrant) switch recombination and are likely to be an early event in myeloma development. A legitimate switch recombination event occurs between two switch regions producing a hybrid switch; this is necessary for class switching to proceed on a productive allele. In this review we describe the process of isotype switching and how illegitimate class switching may be related to the pathogenesis of multiple myeloma.

Citing Articles

Genome instability in multiple myeloma.

Neuse C, Lomas O, Schliemann C, Shen Y, Manier S, Bustoros M Leukemia. 2020; 34(11):2887-2897.

PMID: 32651540 DOI: 10.1038/s41375-020-0921-y.


Immunophenotypic studies of monoclonal gammopathy of undetermined significance.

Olteanu H, Wang H, Chen W, McKenna R, Karandikar N BMC Clin Pathol. 2008; 8:13.

PMID: 19040735 PMC: 2606678. DOI: 10.1186/1472-6890-8-13.


The role of regulatory T cells in allergy.

Curotto de Lafaille M, Lafaille J Springer Semin Immunopathol. 2004; 25(3-4):295-310.

PMID: 15007633 DOI: 10.1007/s00281-003-0144-0.


The rise and fall of long-lived humoral immunity: terminal differentiation of plasma cells in health and disease.

OConnor B, Gleeson M, Noelle R, Erickson L Immunol Rev. 2003; 194:61-76.

PMID: 12846808 PMC: 2827865. DOI: 10.1034/j.1600-065x.2003.00055.x.